Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B | $1.04B | $1.11B | $994.20M |
| Cost of revenue | $478.40M | $441.60M | $466.90M | $477.90M | $468.30M | $447.00M | $457.70M | $400.40M |
| Gross profit | $830.00M | $750.30M | $792.70M | $731.40M | $688.80M | $589.00M | $655.80M | $593.80M |
| Gross margin | 63.4% | 62.9% | 62.9% | 60.5% | 59.5% | 56.9% | 58.9% | 59.7% |
| Research and development | $153.00M | $145.30M | $148.20M | $157.50M | $148.20M | $145.20M | $139.50M | $135.40M |
| Selling, general and administrative | $358.70M | $349.70M | $321.50M | $331.40M | $328.00M | $310.10M | $327.40M | $306.40M |
| Operating expenses | $511.70M | $495.00M | $469.70M | $488.90M | $476.20M | $455.30M | $466.90M | $441.80M |
| Operating income | $318.30M | $255.30M | $323.00M | $242.50M | $212.60M | $133.70M | $188.90M | $152.00M |
| Operating margin | 24.3% | 21.4% | 25.6% | 20.1% | 18.4% | 12.9% | 17.0% | 15.3% |
| EBITDA | $386.50M | $322.40M | $388.20M | $306.10M | $275.60M | $193.70M | $246.70M | $207.30M |
| Interest income | $16.90M | $0 | $0 | — | $28.00M | $0 | $0 | — |
| Interest expense | −$3.00M | $0 | $0 | — | −$4.70M | $0 | $0 | — |
| Income before taxes | $317.50M | $269.50M | $340.70M | $352.30M | $241.10M | $154.30M | $211.30M | $177.40M |
| Income taxes | $68.40M | $70.00M | $73.40M | $68.50M | $61.30M | $48.90M | $59.60M | $42.80M |
| Net income | $249.10M | $199.50M | $267.30M | $283.80M | $179.80M | $105.40M | $151.70M | $134.60M |
| Net margin | 19.0% | 16.7% | 21.2% | 23.5% | 15.5% | 10.2% | 13.6% | 13.5% |
| EPS, basic | $0.65 | $0.52 | $0.69 | $0.73 | $0.46 | $0.27 | $0.39 | $0.34 |
| EPS, diluted | $0.64 | $0.51 | $0.67 | $0.70 | $0.45 | $0.27 | $0.37 | $0.34 |
| Diluted shares | 390.10M | 393.60M | 398.90M | 407.40M | 408.20M | 407.50M | 407.10M | 410.20M |
Figures describe DexCom shares, not any token. As of Jul 30, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.